Judge Vacates $140 Million Verdict in Testosterone Lawsuit
Reading Time: 5 minutes Judge Vacates $140 Million Verdict in Testosterone Lawsuit A federal judge has vacated a massive 140 million dollar verdict over testosterone replacement therapy (TRT) treatment after concluding that the jury’s finding was inconsistent. The lawsuit was filed by Jeffrey Konrad, a Tennessee resident. Konrad claimed in his filing that he suffered a heart attack after two months of testosterone therapy using AndroGel, a topical gel that is used to treat low testosterone (“Low-T”) in older men. AndroGel is manufactured by the large Chicago-based pharmaceutical company AbbVie. In October 2017, a jury awarded Konrad $140,000 in compensatory damages and $140 million...